Jin, Lee-Way <br/><br/>
Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease.  [electronic resource] 

 -  Annals of clinical and translational neurology  Apr 2019 
 - 723-738 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2328-9503 
<br/><br/><label>Standard No.: </label>10.1002/acn3.754  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetamides--pharmacology<br/>Alzheimer Disease--drug therapy<br/>Amyloid beta-Peptides--metabolism<br/>Animals<br/>Brain--drug effects<br/>Drug Repositioning--methods<br/>Humans<br/>Intermediate-Conductance Calcium-Activated Potassium Channels--antagonists & inhibitors<br/>Mice, Transgenic<br/>Microglia--drug effects<br/>Trityl Compounds--pharmacology